JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 9, 2007; DOI: 10.1124/jpet.106.119024


0022-3565/07/3231-70-77$20.00
JPET 323:70-77, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.119024v1
323/1/70    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cavaliere, F.
Right arrow Articles by Volonté, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cavaliere, F.
Right arrow Articles by Volonté, C.

NEUROPHARMACOLOGY

P2 Receptor Antagonist Trinitrophenyl-Adenosine-Triphosphate Protects Hippocampus from Oxygen and Glucose Deprivation Cell Death

Fabio Cavaliere, Susanna Amadio, Klaus Dinkel, Klaus G. Reymann, and Cinzia Volonté

Santa Lucia Foundation, Rome, Italy (F.C., S.A., C.V.); INBIOMED Foundation, San Sebastian, Spain (F.C.); Leibniz Institute for Neurobiology, Magdeburg, Germany (K.D., K.G.R.); Research Institute for Applied Neuroscience, FAN GmbH, Magdeburg, Germany (K.G.R.); and Consiglio Nazionale delle Ricerche, Institute of Neurobiology and Molecular Medicine, Rome, Italy (C.V.)

In this work, we mainly used the organotypic model of rat hippocampus to demonstrate the protective role of the P2 receptor antagonist trinitrophenyl-adenosine-triphosphate (TNP-ATP) during oxygen/glucose deprivation. Among the P2X receptors that TNP-ATP specifically blocks, mainly P2X1 seems to be involved in the processes of cell damage after oxygen/glucose deprivation. P2X1 receptor is strongly and transiently up-regulated in 24 h after an ischemic insult on structures likely corresponding to mossy fibers and Schaffer collaterals of CA1–3 and dentate gyrus. Furthermore, P2X1 receptor is down-regulated by pharmacological treatment with TNP-ATP, which is also found neuroprotective against ischemic cell death. Morphological studies conducted through immunofluorescence and confocal analysis in primary organotypic, in dissociated cultures, and in adult rat in vivo demonstrated the neuronal colocalization of P2X1 protein with neurofilament light chain and neuronal nuclei immunoreactivity in myelinated and unmyelinated fibers of both granular and pyramidal neurons. In conclusion, with this work, we proved the neuronal distribution of P2X1 receptor in hippocampus, and we presented evidence for a potential disadvantageous role of its expression during the path of in vitro ischemia.


Received January 4, 2007; accepted July 6, 2007.

Address correspondence to: Dr. Fabio Cavaliere, Santa Lucia Foundation, Via del Fosso di Fiorano, 64, I-00143 Rome, Italy. E-mail: f.cavaliere{at}hsantalucia.it







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.